of its lower-margin businesses, such as generic drugs and consumer health care products. In 2009, Pfizer merged with Wyeth in a mega-merger valued at around $68 billion. The drug sector���s two leading indexes slipped, echoing the Dow Jones Industrial...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to StemCells shares climb on spinal injury study
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account